ABT
ABBOTT LABORATORIES
ABBOTT LABORATORIES (ABT) Stock News
The latest ABT headlines and market coverage — 1 recent story, updated throughout the day.
- Zacks Investment Research·Neutral
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
Abbott (ABT) declined 2.2% to $111.59 in the latest trading session, underperforming the S&P 500's 0.72% gain. Despite the daily decline, the company has appreciated 5.65% over the past month. Analysts project strong earnings growth with expected EPS of $1.43 (up 10% YoY) and quarterly revenue of $12.91 billion (up 13.52% YoY). Abbott holds a Zacks Rank of #3 (Hold) with a Forward P/E of 20.66, trading at a slight discount to its industry average.